Kestra Advisory Services’s Corcept Therapeutics CORT Stock Holding History

Kestra Advisory Services’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$949K	Buy	+10,914	New	+$659K	﹤0.01%	1868
2026 Q1	–	Sell	-5,194	Closed	-$181K	–	3364
2025 Q4	$181K	Sell	5,194 -1,653	-24%	-$130K	﹤0.01%	2982
2025 Q3	$569K	Sell	6,847 -346	-5%	-$25K	﹤0.01%	1964
2025 Q2	$528K	Buy	7,193 +286	+4%	+$20.7K	﹤0.01%	1931
2025 Q1	$789K	Sell	6,907 -2,618	-27%	-$159K	﹤0.01%	1537
2024 Q4	$480K	Buy	9,525 +1,039	+12%	+$54.4K	﹤0.01%	1899
2024 Q3	$393K	Sell	8,486 -15,860	-65%	-$564K	﹤0.01%	1920
2024 Q2	$791K	Sell	24,346 -6,488	-21%	-$178K	﹤0.01%	1474
2024 Q1	$777K	Buy	+30,834	New	+$728K	0.01%	1400
2021 Q1	–	Sell	-10,072	Closed	-$264K	–	1887
2020 Q4	$264K	Buy	+10,072	New	+$212K	﹤0.01%	1533

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kestra Advisory Services's CORT Position: Q2 2026 in Review

Kestra Advisory Services opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 10,914 shares worth $949K. The stake represents ﹤0.01% of the portfolio and ranks #1868 among its holdings. This is a return to the name: Kestra Advisory Services previously reported a position in CORT as recently as Q4 2025.

Kestra Advisory Services first reported a position in CORT in Q4 2020 and has held it in 10 quarters since. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Kestra Advisory Services held 10,914 shares of Corcept Therapeutics worth $949K as of Q2 2026.
Corcept Therapeutics was a new Kestra Advisory Services position in Q2 2026.
Corcept Therapeutics made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1868 holding.
Kestra Advisory Services first reported a position in Corcept Therapeutics in Q4 2020 and has held it in 10 quarters since.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.